GlassScriptPhysician profile
Sandro James Corti
NPI 1538503131
$893.03
in general payments reported to CMS, 2019-2025
20 companies · none reported in 2025
See the full distribution for Neurology (Psychiatry & Neurology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $651 · 2020: $149 · 2021: $60.21 · 2022: $32.25.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biogen, INC. | $111.76 | 2019-2020 | |
| Abbvie INC. | $92.46 | 2021-2022 | |
| Genentech USA, INC. | $90.95 | 2019-2020 | |
| Jazz Pharmaceuticals INC. | $88.07 | 2019-2020 | |
| Tanabe Pharma America, INC. | $72.53 | 2019-2020 | |
| Alexion Pharmaceuticals, INC. | $71.73 | 2019-2020 | |
| Adamas Pharmaceuticals, INC. | $58.85 | 2019 | |
| Teva Pharmaceuticals USA, INC. | $54.33 | 2019-2020 | |
| Ucb, INC. | $41.65 | 2019 | |
| Aquestive Therapeutics, INC. | $36.83 | 2019 | |
| Greenwich Biosciences, INC. | $36.07 | 2019 | |
| Amneal Pharmaceuticals LLC | $29.37 | 2019 | |
| Amgen INC. | $14.88 | 2019 | |
| Eisai INC. | $14.85 | 2019 | |
| Harmony Biosciences LLC | $14.56 | 2020 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bausch Health US, LLC | $13.95 | 2019 | |
| Promius Pharma LLC | $13.62 | 2019 | |
| Validus Pharmaceuticals LLC | $12.80 | 2019 | |
| Acorda Therapeutics, INC | $12.55 | 2019 | |
| Zyla Life Sciences, INC. | $11.22 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sandro Corti listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.